Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach

DOI10.1111/J.0006-341X.2004.00239.XzbMATH Open1274.62705OpenAlexW2049576630WikidataQ45192037 ScholiaQ45192037MaRDI QIDQ3445321FDOQ3445321

Michael G. Kenward, Tony Vangeneugden, Ariel Alonso, Helena Geys, Geert Molenberghs

Publication date: 11 June 2007

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1111/j.0006-341x.2004.00239.x

Recommendations

• Validation of surrogate markers in multiple randomized clinical trials with repeated measurements
• The evaluation of surrogate endpoints.
• Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
• The Evaluation of Multiple Surrogate Endpoints
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
• The Analysis of Designed Experiments and Longitudinal Data by Using Smoothing Splines
• General class of covariance structures for two or more repeated factors in longitudinal data analysis
• Simplified hierarchical linear models for the evaluation of surrogate endpoints
• The validation of surrogate endpoints in meta-analyses of randomized experiments
• Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach

Cited In (12)

• Fast, closed-form, and efficient estimators for hierarchical models with AR(1) covariance and unequal cluster sizes
• Using earlier measures in a longitudinal sequence as a potential surrogate for a later one
• Testing for misspecification in generalized linear mixed models
• Center-within-trial versus trial-level evaluation of surrogate endpoints
• Quantifying the feasibility of shortening clinical trial duration using surrogate markers
• Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy
• A family of tests to detect misspecifications in the random-effects structure of generalized linear mixed models
• Surrogate Marker Evaluation from an Information Theory Perspective
• Reliability of a longitudinal sequence of scale ratings
• Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach
• Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling
• Type I and Type II Error Under Random‐Effects Misspecification in Generalized Linear Mixed Models

This page was built for publication: Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3445321)